|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | |
| A61K 47/60 |
| (11) | Number of the document | 2771034 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12783783.9 |
| Date of filing the European patent application | 2012-10-25 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/061952 |
| Date | 2012-10-25 |
| (87) | Number | WO 2013/063286 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161551138 P | 2011-10-25 | US |
| (72) |
HOCH, Ute, US
ELDON, Michael, A., US
LEUNG, Abraham, C., F., US
|
| (73) |
Nektar Therapeutics,
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158,
US
|
| (54) | TOPOISOMERASE-I AND-II INHIBITORS FOR USE IN THE TREATMENT OF PATIENTS SUFFERING FROM CANCER |
| TOPOISOMERASE-I AND-II INHIBITORS FOR USE IN THE TREATMENT OF PATIENTS SUFFERING FROM CANCER |